ROARABLE
FREE $100K
Today Screener Big Ideas Track Record 💰 $100K Arena 🎲 Predictions 🏛️ Insiders 8 Analysts
Stock Ratings / Health Care / ELMD
FOCL (28) CV (43) HSDT (31) VANI (28) ⌘ Pro Terminal →

Electromed Inc. (ELMD) — RQD Stock Rating Cockpit

$27.04 -2.31% NYSE • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $26.88

Electromed Inc. (ELMD) carries a Roarable Rating of C (Hold) with 63/100 RQD Confidence. The composite score sits in the neutral Hold band (59–69), meaning current holders don’t need to panic-sell while prospective buyers can wait for a move into the 70+ Buy zone.

ROARABLE C • HOLD / WATCH Cap $224.1M
📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on ELMD Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is ELMD stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼

As of 2026-11-03, Electromed Inc. (NYSE: ELMD) is rated C (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 63/100 at a spot price of $27.04 (-2.31% 1D, market cap $224.1M). Pillar breakdown: Fundamental Cash Engine 17/20, Institutional 13F & Options Flow 4/20, SEC Balance-Sheet Forensics 18/20, FRED Macro Regime Fit 8/20, and Executive Insider Alignment 16/20. Across 1015 tracked Health Care issuers, ELMD ranks #142 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does ELMD compare to FOCL and CV in the Health Care sector?
▼

Within the Health Care sector (Biotechnology: Electromedical & Electrotherapeutic Apparatus), ELMD carries a Roarable C (63/100 RQD), trailing P/E of 30.4x, gross margin of 78.1%, and ROIC of 24.1%. By comparison, FOCL (EDAP TMS S.A.) holds a E grade (28/100 RQD, P/E N/A, ROIC -35.0%, cap $192.1M) and CV (CapsoVision Inc.) posts a D- grade (43/100 RQD, P/E N/A, ROIC -35.0%, cap $363.3M). Among the 5-stock peer group, VANI leads on earnings multiple (3.9x) while ELMD leads on capital efficiency (24.1% ROIC).

✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for ELMD?
▼

Per ELMD's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-06-30, CIK 0001488917), Electromed Inc. generated $64.0M in revenue (+17.0% YoY), $7.5M in net income, and $11.1M in free cash flow against $54.9M in total assets and $0 in total debt. Key quantitative strengths: Strong cash generator (78.1% gross margin)—profits are backed by real money, not accounting tricks. Primary risk factors monitored: Sensitive to high interest rates and tighter Federal Reserve market liquidity. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
🛡️ Portfolio Crash X-Ray
EXT / AFTER-HRS: $26.88 (-0.61%)🧬 Cannibal Buyback (-2.36% YoY Shares)⚙️ Cash Engine: 17/20 (A-) • 17.4% FCF Margin
Verify 90D Bucket Audit →
📊 Historical Track Record: Scores of 63/100 (C) historically posted market-perform odds over rolling 90-day windows (+0.9% avg 90D alpha vs SPY • 54.8% hit rate — wait for RQD ≥ 70 breakout).
Audit Bucket Track Record →
RQD QUANT TACHOMETERHOLD / WATCH • C
025507510063
2-of-3 JEV AI Jury Bullish
Cash
SEC
Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw C · Rk C
Cash (17)Whales (4)SEC (18)Macro (8)CEO (16)
Each axis scored 0–20
12M PRICE TARGET CONE+2.3% Base Target
$50 Bull$28 Base$22 Bear
📬 FREE ELMD RATING-CHANGE & BRIEFING ALERTSManage / Unsubscribe
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for ELMD)Realized 20D OHLCV Swing Band: ±6%
Deterministic 5-Pillar Attribution (63/100 Composite)
🔍 WHY ELMD SCORES 63/100 (C) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: SEC 10-K Forensic Risk+18/20 pts (29% of score)

Altman Z-Score 17.64 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 8/9

▲ #2 Bullish Driver: Cash Engine Quality+17/20 pts (27% of score)

SEC XBRL FY 2025 (10-K): 17.4% FCF Margin ($11.1M FCF) & 78.1% Gross Margin

▼ #1 Drag / Risk Factor: Whale & Options Positioning4/20 pts (-16 pt drag)

Put hedging (50% put share) caps near-term gamma upside (-16 pts vs max)

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)
71
Grade B$27.68-0.9% Next Q
Q2 (-2Q)
68
Grade B-$27.44-2.8% Next Q
Q3 (-1Q)
66
Grade B-$26.66+1.4% Next Q
Current
63
Grade C$27.04+0.9% Hist 90D α
Trajectory: B (71) → C (63)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER

⚔️ Adversarial Opposing Case: Why the ELMD Bull Thesis Could Fail

Gideon Ashmere Forensic Desk →

Even with a 63/100 (C) score, ELMD faces multiple-compression risk if 30.4x trailing P/E re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.

⚠️ Forensic Kill-Switch #1

Sensitive to high interest rates and tighter Federal Reserve market liquidity.

⚠️ Forensic Kill-Switch #2

Dilution & Margin Drag: Cannibal Buyback (-2.36% YoY Shares) — any gross margin slip below 75.6% triggers an automatic RQD downgrade.

⚠️ Forensic Kill-Switch #3

Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($27.87) or 200D SMA ($31.27) invalidates the momentum regime and cuts Target Base ($27.65) toward Bear Floor ($21.57).

🎲 LIVE PREDICTION MARKET ODDS TIED TO $ELMD• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “ELMD Beats Next Quarter EPS Consensus (Dec 28, 2026) & Holds Above 200D SMA”
YES 63%NO 37%Trade / Inspect Odds →
RSI-14 MOMENTUMNEUTRAL RANGE
43.330 Oversold · 70 Hot
ALTMAN-Z SHIELDFORTRESS SAFE (>3.0)
17.64>3.0 Fortress Safe
PIOTROSKI F-SCOREHIGH QUALITY (7–9)
8 / 99-Pt Accounting
52-WEEK LASER RANGE17% OF RANGE
L: $23$27.04H: $47
1. Money & Cash Health● HEALTHY
Are profits real cash in the bank?

Real cash coming in backs up reported profits (78.1% gross margin and healthy balance-sheet cushion).

Factor Grade: A-RQD 17 / 20
2. Big Money & Insiders● TRIMMING
Are whales & executives buying or selling?

Insiders and big institutional desks have been trimming shares rather than stepping up to buy.

Factor Grade: DRQD 20 / 40
3. Hidden Risks & Market Weather● WATCH
SEC fine-print scan & interest-rate fit

No major SEC filing blowups, though current interest rates and Fed liquidity call for normal position sizing.

Factor Grade: CRQD 26 / 40
MULTI-MODEL JEV QUANT JURY DELIBERATION

2-of-3 JEV AI Jury Bullish on ELMD

Cash & Moat Bull AI
ROIC & Free Cash Flow Model
BULLISH (85)

24.1% ROIC with 78.1% gross margin and 4.85% FCF yield.

SEC Forensic Auditor AI
10-K Accruals & Altman-Z Guard
BULLISH (90)

Altman-Z 17.64 and Piotroski 8/9 pass balance-sheet audit.

Whale & Macro Hawk AI
Options Skew, 13F & Fed NetLiq
BEARISH (47)

20/40 institutional & smart-money positioning score with 8/20 macro alignment.

Bull Case: Why Buyers Like ELMD
  • ✓Strong cash generator (78.1% gross margin)—profits are backed by real money, not accounting tricks.
  • ✓Company leadership has skin in the game with net positive insider conviction.
  • ✓Clean SEC annual filing review with no major hidden accounting time-bombs.
Bear Case: What Could Go Wrong
  • !Sensitive to high interest rates and tighter Federal Reserve market liquidity.
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Quantitative Research Desk

Scheduled RQD Strong Buys & Whale Accumulation Briefing (ELMD Tape Review)

  • ✓Breakdown of the highest-scoring RQD Green-Light breakouts across our 5,200+ rated universe
  • ✓Forensic Red-Light accounting & dilution traps to review on your watchlist
  • ✓Includes downloadable .ics calendar invite & nightly RQD rating-change email alerts
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
Join Founding VIP Waitlist (No Card Required) →$100K Arena
ELMD // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +5.79%🛡️ HOLDING TREND SUPPORT
2026-11-03O $27.68H $27.68L $27.04C $27.04VOL 36.5K
RES: $36.01SUP: $26.29SMA50: $27.87SMA200: $31.27
$49.01$42.36$35.71$29.06$22.41RES $36.01SUP $26.29$27.042026-05-042026-06-172026-08-042026-09-182026-11-03
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

ELMD Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 ELMD Butterfly Map → + Track ELMD →
Share Count & Dilution Monitor

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle
23.5%/yr Implied 5Y Growth

vs. +17.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger

No active Ellis Vennor swing setup published on ELMD today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for ELMD. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for ELMD today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (ELMD)

Health Care Rank #142 of 1015 ⚔️ FOCL vs ELMD Full Matrix →

1. Head-to-Head Health Care Peer Comparison (ELMD vs. FOCL, CV, HSDT, VANI)

Industry: Biotechnology: Electromedical & Electrotherapeutic Apparatus (26 Tracked Issuers)

Across 1015 tracked Health Care securities in the Roarable RQD universe, Electromed Inc. (ELMD) ranks #142 by composite RQD confidence (63/100, grade C) and #557 by equity capitalization ($224.1M). Within this direct 5-issuer industry benchmark cohort, VANI leads on earnings valuation at 3.9x trailing P/E, while ELMD leads on capital efficiency and profitability with 24.1% ROIC and 78.1% gross margin. ELMD currently leads its immediate peer cohort in composite quantitative strength at 63/100 (C).

Ticker / Company Roarable Grade RQD Score Trailing P/E Gross Margin ROIC 1D Change Market Cap Head-to-Head
ELMD ACTIVE
Electromed Inc.
C 63/100 30.4x 78.1% 24.1% -2.31% $224.1M Benchmark Subject
FOCL
EDAP TMS S.A.
E 28/100 — 42.5% -35.0% +0.24% $192.1M /focl-vs-elmd →
CV
CapsoVision Inc.
D- 43/100 — 52.9% -35.0% -1.58% $363.3M /cv-vs-elmd →
HSDT
Solana Company (Class A)
E 31/100 — 96.0% -35.0% -7.52% $135.5M /hsdt-vs-elmd →
VANI
Vivani Medical Inc.
E 28/100 3.9x — -35.0% -4.39% $98.3M /vani-vs-elmd →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-06-30 • CIK 0001488917 ↗

In its most recent audited fiscal period (FY2025, filed 2025-06-30), Electromed Inc. (ELMD) reported GAAP revenue of $64.0M (+17.0% vs. FY2024 revenue of $54.7M , and +33.1% cumulative change since FY2023) , GAAP net income of $7.5M, operating cash flow of $11.4M, and free cash flow of $11.1M (+26.8% YoY). On the balance sheet, ELMD closed FY2025 with $54.9M in total assets against $0 in total debt (Altman Z-Score: 17.64, Piotroski F-Score: 8/9).

Fiscal Period Filing Date Revenue Net Income Operating Cash Flow Free Cash Flow Total Assets Total Debt
FY2025 (FY) 2025-06-30 $64.0M $7.5M $11.4M $11.1M $54.9M —
FY2024 (FY) 2024-06-30 $54.7M $5.2M $9.1M $8.8M $52.3M —
FY2023 (FY) 2023-06-30 $48.1M $3.2M $1.3M $1.3M — —

3. ELMD Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is ELMD stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-03, Electromed Inc. (NYSE: ELMD) is rated C (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 63/100 at a spot price of $27.04 (-2.31% 1D, market cap $224.1M). Pillar breakdown: Fundamental Cash Engine 17/20, Institutional 13F & Options Flow 4/20, SEC Balance-Sheet Forensics 18/20, FRED Macro Regime Fit 8/20, and Executive Insider Alignment 16/20. Across 1015 tracked Health Care issuers, ELMD ranks #142 in composite RQD confidence.

How does ELMD compare to FOCL and CV in the Health Care sector?

Within the Health Care sector (Biotechnology: Electromedical & Electrotherapeutic Apparatus), ELMD carries a Roarable C (63/100 RQD), trailing P/E of 30.4x, gross margin of 78.1%, and ROIC of 24.1%. By comparison, FOCL (EDAP TMS S.A.) holds a E grade (28/100 RQD, P/E N/A, ROIC -35.0%, cap $192.1M) and CV (CapsoVision Inc.) posts a D- grade (43/100 RQD, P/E N/A, ROIC -35.0%, cap $363.3M). Among the 5-stock peer group, VANI leads on earnings multiple (3.9x) while ELMD leads on capital efficiency (24.1% ROIC).

What are the biggest fundamental strengths and SEC risk factors for ELMD?

Per ELMD's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-06-30, CIK 0001488917), Electromed Inc. generated $64.0M in revenue (+17.0% YoY), $7.5M in net income, and $11.1M in free cash flow against $54.9M in total assets and $0 in total debt. Key quantitative strengths: Strong cash generator (78.1% gross margin)—profits are backed by real money, not accounting tricks. Primary risk factors monitored: Sensitive to high interest rates and tighter Federal Reserve market liquidity. Institutional options positioning shows a 50% call / 50% put premium split.

Where is ELMD trading relative to its 50-day, 200-day, and 52-week technical levels?

ELMD last traded at $27.04 (-2.31% on volume of 36,454 shares), positioning the stock -2.98% below its 50-day simple moving average ($27.87) and -13.53% below its 200-day simple moving average ($31.27). Across its 52-week range of $23.01 to $47.40, ELMD sits at the 16.5% percentile with a 14-day RSI of 43.3 (NEUTRAL RANGE) and an implied next-earnings move of ±6.0% ($25.42 to $28.66).

Direct Sub-Reports: ELMD RQD Cockpit ELMD 12M Forecast ELMD Earnings & Move ELMD Dividends & DRIP ELMD Insiders & 13F ELMD Whale Options ELMD Profit Sankey ELMD News & Why
ROARABLE RATING BRIEF • RQD 63/100 (C) ✓ SEC XBRL & RQD VERIFIED

ELMD — Electromed Inc.: What the Facts Mean to a Prospective Investor

Methodology: RQD v6.2 Deterministic 5-Pillar & SEC XBRL Audit
Updated: 2025-06-30

1. Roarable Rating Brief: What This Means to a Prospective Investor

Electromed Inc. (ELMD) earns a live Roarable RQD composite score of 63/100, corresponding to a C letter grade (Roarable Hold) at a spot price of $27.04 (-2.31% 1D, market capitalization $224.1M).

  • Fundamental Cash Engine (17/20): Anchored by return on invested capital (ROIC) of 24.1%, gross margin of 78.1%, operating margin of 15.1%, and free cash flow yield of 4.85%.
  • Whale 13F & Options Flow (4/20) + Insider Conviction (16/20): Tracks institutional 13F accumulation, CBOE options call/put positioning, and SEC Form 4 / Congressional PTR filings.
  • Macro Regime Fit (8/20) + Forensic Balance Sheet (18/20): Incorporates a 1.00x equity beta, Altman Z-Score of 17.64, Piotroski F-Score of 8/9, and Debt/Equity of N/A.

2. Business Model, Unit Margins & SEC Financial Trajectory

Electromed Inc. (ELMD) is a NYSE-listed issuer in the Health Care sector, operating within the Biotechnology: Electromedical & Electrotherapeutic Apparatus industry,. Per the market data, gross margin is 78.1%, operating margin 15.1%, and net margin 11.8%.

In its latest audited SEC EDGAR 10-K filing for FY2025 (filed 2025-06-30), Electromed Inc. (ELMD) reported $64.0M in annual revenue (up from $54.7M in FY2024, +17.0% YoY) and $7.5M in GAAP net income. Over the multi-year SEC filing window from FY2023 ($48.1M revenue, $3.2M net income) through FY2025, ELMD scaled operating cash flow to $11.4M and free cash flow to $11.1M, backed by $54.9M in total assets against $0 in total debt.

3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff

  • 🐂 Primary Bull Case (C • RQD 63/100): Strong cash generator (78.1% gross margin)—profits are backed by real money, not accounting tricks. Company leadership has skin in the game with net positive insider conviction. With Fundamental Cash Engine at 17/20 and Institutional Whale Flow at 4/20, sustained execution supports upside toward the upper end of the $23.01 – $47.40 52-week range.
  • 🐻 Primary Bear Case & Valuation Risk: Sensitive to high interest rates and tighter Federal Reserve market liquidity. Investors must weigh 30.4x trailing P/E and 21.8x EV/EBITDA against 15.1% operating margins and a 1.00x macro beta.

4. 2nd-Order Butterfly Ripples & Key Questions to Watch

The one investor-relevant watch item from the news feed is the scheduled Q1 Fiscal 2027 report on November 10, 2026, which per the news feed is a near-term event; its downstream effects are not described in the source data.

  • Key Question #1: Can ELMD sustain or expand its 15.1% operating margin and 24.1% ROIC against Biotechnology: Electromedical & Electrotherapeutic Apparatus peers over the next 4 quarters?
  • Key Question #2: Following FY2025 revenue of $64.0M and free cash flow of $11.1M, how will capital allocation balance growth reinvestment against $0 in total debt?
  • Key Question #3: How sensitive is ELMD's 25.5x forward P/E multiple to Health Care capital spending cycles and macro interest-rate shifts (Beta 1.00x)?

ELMD Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for Electromed Inc. (ELMD) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to ELMD Debate Forum (3) ↓
🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

ELMD Bull vs. Bear Conversation Board — What's Your Call at $27.04?

🐂 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON ELMD 🐻 33% BEARISH CONVICTION
1. Pick Your Side on ELMD:
💡 Tip: Back up your call with a price target or RQD metric to get upvoted to the top.
CA CashFlowKing RQD DEBATE OPENER • FCF Compounder Hunter 🐂 BULLISH 🎯 Target: $32.45 (+20.0%)
📌 Pinned Debate

Cash generation is strong, with ROIC of 24.1%, FCF yield of 4.85%, and revenue growing from $48.1M to $64.0M over FY 2023–FY 2025.

Long ELMD at $27.04 targeting $32.45. Cash generation is strong, with ROIC of 24.1%, FCF yield of 4.85%, and revenue growing from $48.1M to $64.0M over FY 2023–FY 2025.. Institutional whale score is 4/20 and the risk/reward vs. the $23.01 52-week low is skewed heavily in favor of bulls.

VolSurface_Trader 🐂 BULL

Both sides have a point here — ELMD's 18/20 balance sheet score keeps downside contained, so the real swing factor next earnings call is backlog and FCF conversion.

RI RiskArb_Desk RQD DEBATE OPENER • Hedged Event Driven 🐻 BEARISH 🎯 Target: $22.17 (-18.0%)
Spot @ $27.04

Institutional flow scores just 6 / 20 and macro fit 8 / 20, while the stock trades at 30.4x TTM P/E with a Beta of 1.0.

Fading this rally in ELMD at $27.04. Institutional flow scores just 6 / 20 and macro fit 8 / 20, while the stock trades at 30.4x TTM P/E with a Beta of 1.0.. With a beta of 1.0 and the stock sitting at $27.04 (52-wk range $23.01–$47.40), the easy multiple expansion is already priced in.

LIVE TAPE SPY $752.10 -1.80% QQQ $681.09 -3.60% DIA $519.34 -1.08% IWM $279.14 -1.68% NVDA $204.64 -4.22% AAPL $344.63 -1.23% MSFT $521.91 -1.55% TSLA $399.81 -0.86% PLTR $184.11 -6.27% SOFI $16.76 -4.83% IBIT $43.35 -5.42% GLD $361.65 -3.59%